Influence of Physical Treatments of Human Milk on the Kinetics of Gastric Lipolysis in Preterm Newborns
NCT02112331 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-05-23
Summary
The optimization of newborns nutrition is a challenge especially for preterm newborns for whom nutrition plays a crucial part in cerebral and global development. Human milk is considered as the best food for newborns. Several short and long-term beneficial health effects were attributed to breastfeeding and have induced the increase of human milk in preterm newborns nutrition.
Whereas the chemical composition of infant formula has been optimized to mimic human milk, there is still a major difference between the structure of human milk and commercial infant formulas. It is well known in adult nutrition that the structure of emulsions influences their susceptibility to hydrolysis, such results have been obtained either on in vitro or in vivo studies.
Human milk is a natural emulsion (oil in water). Lipids droplets are dispersed under the form of entities called milk fat globules (average diameter 4 µm, span 0.1-20 μm). The globules are stabilized by a trilayered membrane composed mainly of polar lipids (phospholipids, sphingolipids and gangliosides), of proteins, neutral lipids and other minor compounds.
The physical treatments apply to human milk or more generally to bovine milk to pasteurize or stabilize the milk modify the structure of the natural emulsion. Heat treatment for instance induces whey proteins denaturation and the adsorption of protein aggregates on the surface of the milk fat globules. Heat treatment also leads to the denaturation of bile salt stimulated lipase. These effects limit intragastric lipolysis in preterm newborns.
Conversely, reduction of milk globules size, by homogenisation of milk, increases the specific surface available for lipase adsorption and limits the lost of fat during enteral administration of milk. Such treatment could thus enhance gastric lipolysis and improve fat absorption of preterm newborns.
The objective of this trial is to evaluate the effects of physical treatments (pasteurization and homogenisation by ultrasonication) applied to human milk on gastric lipolysis and milk destructuration. This trial is conducted, in vivo, on preterm newborns.
Conditions
- Premature Birth
Interventions
- OTHER
-
Raw human milk
- OTHER
-
Pasteurized human milk
- OTHER
-
Pasteurized-homogenized human milk
- OTHER
-
Gastric samples
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Patrick Pladys, MD, PhD · Pôle de pédiatrie, CHU de Rennes, FRANCE
-
Didier Dupont · Agrocampus Ouest - Département AgroAlimentaire UMR 1253 INRA " Science et Technologie du Lait et de l'Oeuf ", Rennes, FRANCE
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Days
- Max Age
- 21 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2015-08-31
- Completion
- 2016-04-30
Countries
- France
Study Locations
More Related Trials
-
Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility
NCT03552510 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns
NCT05097924 ·Status: COMPLETED
-
Growth and Nutritional Status of Very Low Birth Weight Infants Fed a High Protein Exclusive Human Milk Diet
NCT03839173 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness and Safety of Fast Enteral Feeding in Preterm Infants Between 1000 and 2000 Grams of Birth Weight
NCT02998489 ·Status: COMPLETED ·Phase: NA
-
Feeding Bovine Colostrum to Preterm Infants
NCT02054091 ·Status: COMPLETED ·Phase: NA
-
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
NCT06072976 ·Status: RECRUITING ·Phase: NA
-
Fact-based Nutrition for Infants and Lactating Mothers
NCT05646940 ·Status: COMPLETED
-
Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants
NCT00506584 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Different Protein Content of Formulas on Nutrition Status of Infants.
NCT03513991 ·Status: COMPLETED ·Phase: NA
-
Human Milk Oligosaccharides (HMOs) Post-market Study on Infants (NEHMO)
NCT05150288 ·Status: COMPLETED ·Phase: NA
-
Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants
NCT01534481 ·Status: COMPLETED ·Phase: PHASE3
-
Protein Balance and Body Composition in Preterm Infants
NCT03013374 ·Status: UNKNOWN
-
Nutrition of Premature Infants With Human Breastmilk Fortifier
NCT03191617 ·Status: UNKNOWN ·Phase: NA
-
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
NCT02632266 ·Status: COMPLETED ·Phase: PHASE4
-
Impact Assessment of Abdominal Massage on Feeding Tolerance of Preterms
NCT06351202 ·Status: RECRUITING ·Phase: NA
-
Human Milk Fortification in Very Low Birth Neonates
NCT01988792 ·Status: COMPLETED ·Phase: NA
-
HMF Preterm Case Studies
NCT05057390 ·Status: COMPLETED ·Phase: NA
-
Impact of Infant Feeding on Newborn Metabolomic Profile
NCT01606683 ·Status: COMPLETED ·Phase: NA
-
Growth and Microbiome Development in Very Low Birth Weight Infants Fed Primarily Mother's Own Milk vs. Donor Human Milk
NCT02573779 ·Status: COMPLETED
-
Effects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTS
NCT01965769 ·Status: COMPLETED ·Phase: NA
-
Enrichment of Human Milk With Human and Bovine Milk-based Fortifiers for Very Preterm Infants: a Meta-analysis
NCT06870318 ·Status: COMPLETED
-
Effect of the Level of Dietary Protein on the Infant Hormonal Profile and Body Composition
NCT02282488 ·Status: COMPLETED ·Phase: NA
-
Re-feeding Gastric Residuals in Preterm Infants
NCT01420263 ·Status: COMPLETED ·Phase: NA
-
Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum
NCT05481866 ·Status: UNKNOWN ·Phase: NA
-
Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants
NCT01413581 ·Status: TERMINATED ·Phase: PHASE3